AMRX - Amneal Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$17.33
DETAILS
HIGH:
$19.00
LOW:
$16.00
MEDIAN:
$17.00
CONSENSUS:
$17.33
UPSIDE:
39.53%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Revenue | 3,018.8 | 2,794.0 | 2,393.6 | 2,212.3 | 2,093.7 | 1,992.5 | 1,626.4 | 1,663.0 | 1,033.7 | 1,018.2 | 866.3 | 785.6 |
| Cost of Revenue | 1,882.7 | 1,773.5 | 1,529.7 | 1,420.8 | 1,324.7 | 1,364.1 | 1,273.4 | 946.6 | 507.5 | 420.8 | 367.1 | 336.0 |
| Gross Profit | 1,136.1 | 1,020.4 | 863.9 | 791.5 | 769.0 | 628.4 | 353.0 | 716.4 | 526.2 | 597.5 | 499.2 | 449.6 |
| Operating Expenses | ||||||||||||
| R&D Expenses | 186.2 | 190.7 | 194.8 | 208.7 | 209.6 | 190.6 | 202.3 | 210.5 | 191.9 | 204.7 | 136.9 | 106.7 |
| SG&A Expenses | 526.8 | 476.4 | 429.7 | 399.7 | 365.5 | 326.7 | 289.6 | 230.4 | 109.0 | 118.8 | 109.7 | 84.6 |
| Other Expenses | 0 | 104.0 | 35.1 | 278.0 | 41.2 | 19.9 | 109.8 | 2.8 | (0.0) | (0.7) | 0 | 0 |
| Operating Expenses | 713.0 | 771.1 | 659.5 | 886.4 | 616.3 | 537.2 | 601.7 | 440.9 | 301.0 | 323.5 | 277.8 | 239.6 |
| Operating Income | ||||||||||||
| Operating Income | 423.1 | 249.3 | 204.4 | (94.9) | 152.7 | 91.2 | (248.7) | (19.7) | 245.1 | 284.9 | 227.2 | 222.9 |
| Interest Expense | 241.1 | 258.6 | 210.6 | 158.4 | 136.3 | 146.0 | 168.2 | 143.6 | 71.1 | 55.3 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 158.4 | 0 | 0 | 0 | 0 | 0 | 0 | 45.8 | 30.7 |
| Profitability | ||||||||||||
| EBITDA | 603.9 | 439.8 | 500.8 | 440.2 | 401.1 | 345.6 | 155.2 | (19.7) | 271.1 | 307.0 | 252.7 | 243.3 |
| EBIT | 380.3 | 203.6 | 271.4 | 200.0 | 167.7 | 110.2 | (52.0) | (59.2) | 242.4 | 270.1 | 227.2 | 222.9 |
| Income Before Tax | 139.2 | (55.0) | (40.3) | (248.1) | 31.4 | (35.8) | (220.2) | (202.7) | 171.3 | 214.8 | 175.6 | 179.3 |
| Income Tax Expense | 11.3 | 18.9 | 8.5 | 6.7 | 11.2 | (104.4) | 383.3 | (1.4) | 2.0 | 5.4 | 5.0 | 1.5 |
| Net Income | 72.1 | (116.9) | (84.0) | (130.0) | 10.6 | 91.1 | (361.9) | (169.7) | 167.6 | 207.4 | 169.5 | 176.9 |
| Per Share Data | ||||||||||||
| EPS (Basic) | 0.23 | -0.38 | -0.48 | -0.86 | 0.07 | 0.62 | -4.57 | -1.33 | 1.46 | 1.10 | 0.90 | 0.94 |
| EPS (Diluted) | 0.22 | -0.38 | -0.48 | -0.86 | 0.07 | 0.61 | -4.57 | -1.33 | 1.46 | 1.10 | 0.90 | 0.94 |
| Shares Outstanding | 313.4 | 309.0 | 175.0 | 150.9 | 148.9 | 149.3 | 132.1 | 127.3 | 114.9 | 189.0 | 189.0 | 189.0 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 310.9 | 110.6 | 91.5 | 26.0 | 247.8 | 341.4 | 151.2 | 213.4 | 74.2 | 27.4 |
| Short-Term Investments | 0 | 1.9 | 2.2 | 1.8 | 0 | 1.7 | 1.1 | 0 | 0 | 4.4 |
| Net Receivables | 939.9 | 775.7 | 645.7 | 741.8 | 694.7 | 639.0 | 604.4 | 565.3 | 351.4 | 394.8 |
| Inventory | 606.3 | 612.5 | 581.4 | 530.7 | 489.4 | 490.6 | 381.1 | 457.2 | 284.0 | 266.2 |
| Other Current Assets | 4.4 | 40.7 | 7.6 | 64.4 | 41.9 | 41.0 | 33.1 | 52.8 | 35.1 | 22.7 |
| Total Current Assets | 1,911.2 | 1,587.8 | 1,377.9 | 1,411.8 | 1,520.1 | 1,551.5 | 1,210.2 | 1,286.6 | 771.9 | 726.1 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 550.3 | 523.7 | 550.1 | 589.4 | 639.0 | 604.7 | 620.6 | 544.1 | 486.8 | 407.4 |
| Goodwill | 595.5 | 597.4 | 598.6 | 598.9 | 593.0 | 522.8 | 419.5 | 426.2 | 26.4 | 28.4 |
| Intangible Assets | 563.5 | 732.4 | 890.4 | 1,096.1 | 1,166.9 | 1,304.6 | 1,382.8 | 1,655.0 | 44.6 | 45.9 |
| Long-Term Investments | 7.8 | 35.9 | 37.1 | 85.6 | 0 | 0 | 16.4 | 0 | 0 | 0 |
| Other Non-Current Assets | 50.0 | 24.2 | 18.4 | 17.6 | 20.6 | 22.3 | 16.5 | 67.6 | 11.3 | (481.8) |
| Total Non-Current Assets | 1,767.1 | 1,913.6 | 2,094.7 | 2,387.5 | 2,419.6 | 2,454.5 | 2,455.7 | 3,066.1 | 570.0 | 481.8 |
| Total Assets | 3,678.3 | 3,501.4 | 3,472.6 | 3,799.3 | 3,939.7 | 4,006.0 | 3,665.9 | 4,352.7 | 1,341.9 | 1,218.8 |
| Current Liabilities | ||||||||||
| Account Payables | 254.7 | 259.8 | 143.6 | 166.8 | 131.1 | 154.1 | 103.0 | 114.8 | 70.0 | 60.0 |
| Short-Term Debt | 21.6 | 324.2 | 213.1 | 90.0 | 30.6 | 45.2 | 21.5 | 21.4 | 89.2 | 36.9 |
| Deferred Revenue | 0 | 0 | 398.4 | 0 | 0 | 0 | 0 | 17.4 | 137.1 | 0 |
| Other Current Liabilities | 525.5 | 222.4 | 3.9 | 263.1 | 120.1 | 207.3 | 176.3 | 200.8 | 72.2 | 63.8 |
| Total Current Liabilities | 881.6 | 1,129.8 | 846.6 | 752.8 | 677.2 | 676.9 | 550.4 | 553.9 | 296.9 | 225.1 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 2,612.5 | 2,161.8 | 2,427.5 | 2,631.7 | 2,718.1 | 2,825.6 | 2,609.0 | 2,630.6 | 1,355.3 | 1,159.6 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.2 | 2.5 | 0 |
| Other Non-Current Liabilities | 75.8 | 163.3 | 41.8 | 97.1 | 65.4 | 31.0 | 35.7 | 231.7 | 10.3 | (0.9) |
| Total Non-Current Liabilities | 2,790.7 | 2,416.2 | 2,564.7 | 2,837.6 | 2,895.4 | 2,972.4 | 2,768.7 | 2,902.5 | 1,420.6 | 1,159.6 |
| Total Liabilities | 3,672.3 | 3,546.0 | 3,411.3 | 3,590.4 | 3,572.7 | 3,649.3 | 3,319.1 | 3,456.4 | 1,717.5 | 1,394.8 |
| Stockholders' Equity | ||||||||||
| Common Stock | 3.1 | 3.1 | 3.1 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 2.7 | 2.7 |
| Retained Earnings | (535.0) | (607.1) | (490.2) | (406.2) | (276.2) | (286.8) | (377.9) | (20.9) | (382.8) | (175.2) |
| Accumulated Other Comprehensive Income | (110.7) | (65.5) | (32.3) | 9.9 | (24.8) | (41.3) | (0.1) | (7.8) | (14.2) | 0 |
| Total Stockholders' Equity | (70.8) | (109.3) | 19.8 | 298.4 | 360.3 | 303.3 | 232.0 | 896.4 | (385.7) | (185.3) |
| Total Liabilities & Equity | 3,678.3 | 3,501.4 | 3,472.6 | 3,799.3 | 3,939.7 | 4,006.0 | 3,665.9 | 4,352.7 | 1,341.9 | 0 |
| Debt Metrics | ||||||||||
| Total Debt | 2,736.5 | 2,593.1 | 2,750.5 | 2,845.1 | 2,876.1 | 2,998.8 | 2,769.9 | 2,691.4 | 1,484.7 | 1,197.5 |
| Net Debt | 2,425.6 | 2,482.6 | 2,659.0 | 2,819.2 | 2,628.3 | 2,657.4 | 2,618.7 | 2,478.0 | 1,410.6 | 1,170.1 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | 72.1 | (73.9) | (48.7) | (254.8) | 10.6 | 91.1 | (603.6) | (201.3) | 169.3 | 209.4 |
| Depreciation & Amortization | 223.6 | 236.2 | 229.4 | 240.2 | 233.4 | 244.1 | 207.2 | 137.4 | 45.9 | 33.0 |
| Stock-Based Compensation | 32.0 | 27.8 | 26.8 | 31.8 | 0 | 20.8 | 21.7 | 167.6 | 0 | 0 |
| Change in Working Capital | (204.5) | (4.1) | (47.2) | (59.9) | (133.6) | (61.6) | (120.2) | 7.0 | (1.0) | (152.2) |
| Other Non-Cash Items | 216.9 | 109.1 | 185.3 | 107.8 | 131.4 | 84.8 | 124.9 | 149.0 | 14.5 | 3.3 |
| Operating Cash Flow | 340.0 | 295.1 | 345.6 | 65.1 | 241.8 | 379.0 | 1.7 | 250.2 | 234.2 | 115.1 |
| Investing Activities | ||||||||||
| Capital Expenditure | (70.1) | (75.0) | (69.2) | (90.6) | (47.7) | (61.8) | (97.4) | (97.1) | (114.3) | (124.6) |
| Acquisitions | 0 | 12.0 | 0 | (84.7) | (141.5) | (251.4) | 34.8 | (324.6) | 15.7 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (42.2) | (14.7) | (22.4) | (40.8) | (3.2) | (4.3) | (7.2) | 25.3 | (3.8) | (1.9) |
| Investing Cash Flow | (112.3) | (63.0) | (69.2) | (174.3) | (194.2) | (317.5) | (19.6) | (396.4) | (98.6) | (124.6) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 26.3 | (185.1) | 22.7 | (38.3) | (79.2) | 143.0 | (29.3) | 541.0 | 286.1 | 188.6 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | (0.9) | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (183.0) | (375.3) | (200.6) |
| Other Financing Activities | (59.8) | (26.7) | (235.2) | (68.3) | (59.8) | (10.3) | (16.6) | (70.4) | (5.9) | (7.5) |
| Financing Cash Flow | (31.5) | (211.8) | (212.6) | (106.6) | (138.1) | 131.8 | (45.8) | 287.7 | (95.0) | (19.5) |
| Cash Position | ||||||||||
| Net Change in Cash | 194.5 | 19.3 | 63.9 | (221.5) | (90.4) | 194.3 | (66.0) | 140.9 | 40.4 | (27.6) |
| Cash at Beginning | 118.4 | 99.1 | 35.2 | 256.7 | 347.1 | 152.8 | 218.8 | 77.9 | 37.5 | 65.1 |
| Cash at End | 312.9 | 118.4 | 99.1 | 35.2 | 256.7 | 347.1 | 152.8 | 218.8 | 77.9 | 37.5 |
| Free Cash Flow | 269.9 | 220.1 | 276.4 | (25.5) | 194.1 | 317.2 | (95.7) | 153.1 | 119.9 | (9.5) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||
| Revenue | 3,018.8 | 2,794.0 | 2,393.6 | 2,212.3 | 2,093.7 | 1,992.5 | 1,626.4 | 1,663.0 | 1,033.7 | 1,018.2 | 866.3 | 785.6 |
| Gross Profit | 1,136.1 | 1,020.4 | 863.9 | 791.5 | 769.0 | 628.4 | 353.0 | 716.4 | 526.2 | 597.5 | 499.2 | 449.6 |
| Operating Income | 423.1 | 249.3 | 204.4 | (94.9) | 152.7 | 91.2 | (248.7) | (19.7) | 245.1 | 284.9 | 227.2 | 222.9 |
| Net Income | 72.1 | (116.9) | (84.0) | (130.0) | 10.6 | 91.1 | (361.9) | (169.7) | 167.6 | 207.4 | 169.5 | 176.9 |
| EPS (Diluted) | 0.22 | -0.38 | -0.48 | -0.86 | 0.07 | 0.61 | -4.57 | -1.33 | 1.46 | 1.10 | 0.90 | 0.94 |
| Balance Sheet | ||||||||||||
| Cash & Equivalents | 310.9 | 110.6 | 91.5 | 26.0 | 247.8 | 341.4 | 151.2 | 213.4 | 74.2 | 27.4 | ||
| Total Assets | 3,678.3 | 3,501.4 | 3,472.6 | 3,799.3 | 3,939.7 | 4,006.0 | 3,665.9 | 4,352.7 | 1,341.9 | 1,218.8 | ||
| Total Debt | 2,736.5 | 2,593.1 | 2,750.5 | 2,845.1 | 2,876.1 | 2,998.8 | 2,769.9 | 2,691.4 | 1,484.7 | 1,197.5 | ||
| Stockholders' Equity | (70.8) | (109.3) | 19.8 | 298.4 | 360.3 | 303.3 | 232.0 | 896.4 | (385.7) | (185.3) | ||
| Cash Flow | ||||||||||||
| Operating Cash Flow | 340.0 | 295.1 | 345.6 | 65.1 | 241.8 | 379.0 | 1.7 | 250.2 | 234.2 | 115.1 | ||
| Capital Expenditure | (70.1) | (75.0) | (69.2) | (90.6) | (47.7) | (61.8) | (97.4) | (97.1) | (114.3) | (124.6) | ||
| Free Cash Flow | 269.9 | 220.1 | 276.4 | (25.5) | 194.1 | 317.2 | (95.7) | 153.1 | 119.9 | (9.5) | ||